Opthea

Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO
Fierce Biotech
Fri, 09/25/20 - 10:35 am
Opthea
IPOs
wet age-related macular degeneration
Opthea Reports Positive Data from Ph Ib Study for Diabetic Macular Edema Drug
CP Wire
Fri, 10/26/18 - 11:50 am
Opthea
OPT-302
diabetic macular edema
Opthea Reports Positive Data from Ph Ib Study for Diabetic Macular Edema Drug
Fri, 10/26/18 - 09:52 am
Opthea
OPT-302
diabetic macular edema
Opthea touts data from wet-AMD trial
Drug Delivery Business News
Tue, 08/15/17 - 10:01 am
Opthea
clnical trials
wet-AMD
OPT-302
anti-VEGF